Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interactions between tacrolimus and antimicrobial agents

D L Paterson1, N Singh

  • 1Infectious Disease Section, Veterans Affairs Medical Center, Pittsburgh, Pennsylvania 15240, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|February 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time investigation of a Burkholderia cenocepacia bacteraemia outbreak in a Vietnamese intensive care unit.

The Journal of hospital infection·2025
Same author

The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions-a randomised controlled trial.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2021
Same author

Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Measuring patient-centred long-term outcome following a bloodstream infection: a pilot study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.

Pathology·2018
Same author

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

International journal of antimicrobial agents·2018
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Antimicrobial drugs can significantly alter tacrolimus levels in transplant patients by affecting cytochrome P-450 3A enzymes. This can lead to either dangerous toxicity or increased risk of organ rejection.

Area of Science:

  • Pharmacology
  • Transplantation Medicine
  • Drug Interactions

Background:

  • Tacrolimus is a vital immunosuppressant for transplant recipients.
  • Its metabolism is primarily governed by the cytochrome P-450 3A (CYP3A) enzyme system.
  • Tacrolimus exhibits potential nephrotoxic and neurotoxic effects, dose-dependently.

Purpose of the Study:

  • To examine the impact of antimicrobial agents on tacrolimus blood levels.
  • To highlight the clinical significance of drug-drug interactions involving tacrolimus and antimicrobials.
  • To underscore the risk of toxicity and organ rejection due to altered tacrolimus pharmacokinetics.

Main Methods:

  • Review of existing literature on tacrolimus metabolism and drug interactions.
  • Analysis of how CYP3A inhibitors and inducers affect tacrolimus pharmacokinetics.

Related Experiment Videos

  • Assessment of the clinical consequences of these interactions in transplant recipients.

    • Main Results:

    • Antimicrobials inhibiting CYP3A increase tacrolimus levels, raising toxicity risks (nephrotoxicity, neurotoxicity).
    • Antimicrobials inducing CYP3A decrease tacrolimus levels, increasing acute rejection risk.
    • Concurrent use of nephrotoxic antimicrobials exacerbates tacrolimus-induced renal damage.

    Conclusions:

    • Careful consideration of antimicrobial drug interactions is crucial for tacrolimus-treated patients.
    • Prescribing antimicrobials requires a thorough review of potential effects on tacrolimus levels.
    • Proactive management of drug interactions can mitigate tacrolimus toxicity and improve transplant outcomes.